Rheumatoid arthritis patients exhibit impaired Candida albicans-specific Th17 responses

@inproceedings{Bishu2014RheumatoidAP,
  title={Rheumatoid arthritis patients exhibit impaired Candida albicans-specific Th17 responses},
  author={Shrinivas Bishu and Ee Wern Su and Erich R Wilkerson and Kelly A Reckley and Donald P Jones and Mandy J McGeachy and Sarah L Gaffen and Marc C. Levesque},
  booktitle={Arthritis research & therapy},
  year={2014}
}
INTRODUCTION Accumulating data implicate the CD4+ T cell subset (Th17 cells) in rheumatoid arthritis (RA). IL-17 is an inflammatory cytokine that induces tumor necrosis factor (TNF)α, IL-1β and IL-6, all of which are targets of biologic therapies used to treat RA. RA patients are well documented to experience more infections than age-matched controls, and… CONTINUE READING